| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,246 | 34,325 | 33,290 | 38,410 | | Cost of Revenue | (42,750) | 22,487 | 20,263 | 4,015 | | | Gross Profit | 81,996 | 11,838 | 13,027 | 34,395 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 83,862 | 14,699 | 16,964 | 37,587 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 940 | 931 | 939 | 3,787 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,992) | (3,792) | (4,876) | (6,979) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,806) | (3,792) | (4,876) | (6,979) | | Interest Expense | 1,014 | 1,048 | 1,124 | 1,060 | | Income Before Tax | (3,820) | (4,840) | (6,000) | (8,039) | | Income Tax Expense | (92) | 318 | 241 | 267 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,728) | (5,158) | (6,241) | (8,306) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,728) | (5,158) | (6,241) | (8,306) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,728) | ($5,158) | ($6,241) | ($8,306) |
|
0.02% Nasdaq 0.00%
Income Statement
